Newbridge Financial Services Group, Inc. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 216 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,789
-33.2%
4,600
-23.3%
0.00%0.0%
Q2 2023$2,679
-45.5%
6,0000.0%0.00%
-66.7%
Q1 2023$4,920
-47.4%
6,0000.0%0.00%
-40.0%
Q4 2022$9,360
-6.4%
6,0000.0%0.01%
-16.7%
Q3 2022$10,0000.0%6,0000.0%0.01%0.0%
Q2 2022$10,000
-54.5%
6,0000.0%0.01%
-45.5%
Q1 2022$22,000
-26.7%
6,0000.0%0.01%
-21.4%
Q4 2021$30,000
-30.2%
6,0000.0%0.01%
-48.1%
Q3 2021$43,000
-23.2%
6,0000.0%0.03%
-20.6%
Q2 2021$56,0000.0%6,0000.0%0.03%
-17.1%
Q1 2021$56,0006,0000.04%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders